in the magazine

From the Editor-in-Chief

Surrogate endpoints can speed up drug approvals, but are they valid measures of effectiveness?

by William G. Nelson, MD, PhD

Forward Look

Cancer Death Rate Decline Makes Headlines | Cancer Treatments and Antioxidant Supplements Can Be a Bad Mix | Here Come the Biosimilars | More Treatments Approved for Metastatic Breast Cancer | What’s Next? Summer 2020

Your Cancer Guide

During the COVID-19 pandemic, cancer survivors can tap into familiar lessons of resiliency.

by Hester Hill Schnipper

Caregiving With Confidence

Accepting this emotion can be the first step in channeling it for a constructive purpose.

by Karen J. Bannan

Policy Matters

The AACR and the FDA presented joint recommendations that include broadening clinical trial eligibility and engaging the community in clinical trial recruitment.

by Kenneth C. Anderson, MD; Lola A. Fashoyin-Aje, MD, MPH; Nicole Gormley, MD; and Paul G. Kluetz, MD

Cancer patients with chronic pain and the physicians who treat them strive to address pain while avoiding potential opioid abuse and addiction.

by Charlotte Huff

With recent advances in targeted treatments, people diagnosed with chronic lymphocytic leukemia have more options to manage the disease.

by Kendall K. Morgan

Using robotic assistants for cancer surgery has become commonplace. Whether cancer patients benefit when a surgeon uses a robot remains unclear.

by Sue Rochman

Survivor Profile

Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.

by Lindsey Konkel

Healthy Habits

Active Treatment | One Drink, Too Many?

Q&A

In her first book, journalist and breast cancer survivor Kate Pickert traces the winding road of cancer research and patient advocacy.

by Marci A. Landsmann

Sound Advice

Weight gain during treatment, conversations about sex, and what to know about a loved one's insurance.

Facts and Stats

While advances have been made in treating lung cancer and risk reduction, there is still plenty of work to be done.

by Bradley Jones